Mirova Us LLC Edwards Lifesciences Corp Transaction History

Mirova Us LLC

$7.92 Billion
Q4 2024

A detailed history of Mirova Us LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Mirova Us LLC holds 1,809,222 shares of EW stock, worth $124 Million. This represents 1.69% of its overall portfolio holdings.

Number of Shares

1,809,222

Previous 1,863,132 2.89%

Holding current value

$124 Million

Previous $123 Million 8.94%

% of portfolio

1.69%

Previous 1.46%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	SELL	$64.54 - $75.92 $3.48 Million - $4.09 Million	-53,910 Reduced 2.89%	1,809,222 $134 Million
Q3 2024 Nov 14, 2024	BUY	$59.7 - $93.78 $59.7 Million - $93.8 Million	1,000,066 Added 115.87%	1,863,132 $123 Million
Q2 2024 Jul 30, 2024	BUY	$84.3 - $94.31 $1.46 Million - $1.64 Million	17,365 Added 2.05%	863,066 $79.7 Million
Q1 2024 May 09, 2024	SELL	$72.54 - $95.56 $1.07 Million - $1.4 Million	-14,699 Reduced 1.71%	845,701 $80.8 Million
Q4 2023 Jan 30, 2024	SELL	$61.71 - $77.76 $317,806 - $400,464	-5,150 Reduced 0.59%	860,400 $65.6 Million
Q3 2023 Nov 13, 2023	BUY	$69.28 - $93.38 $2.33 Million - $3.14 Million	33,641 Added 4.04%	865,550 $60 Million
Q2 2023 Jul 24, 2023	BUY	$81.41 - $94.33 $1.61 Million - $1.87 Million	19,816 Added 2.44%	831,909 $78.5 Million
Q1 2023 May 02, 2023	BUY	$74.26 - $84.51 $684,008 - $778,421	9,211 Added 1.15%	812,093 $67.2 Million
Q4 2022 Feb 09, 2023	BUY	$68.3 - $87.44 $1.33 Million - $1.7 Million	19,423 Added 2.48%	802,882 $59.9 Million
Q3 2022 Nov 03, 2022	BUY	$82.37 - $107.29 $64.5 Million - $84.1 Million	783,459 New	783,459 $64.7 Million

Others Institutions Holding EW

# of Institutions

1,382

Shares Held

487M

Call Options Held

6.71M

Put Options Held

3.17M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $42.4B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirova Us LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mirova Us LLC with notifications on news.

Account